Your browser doesn't support javascript.
loading
Structural and Functional Impact of Adrenoceptor Beta-1 Gene Polymorphism in Patients with Hypertrophic Cardiomyopathy and Response to Beta-Blocker Therapy.
Raimoglou, Damla; Izgi, Cemil; Enar, Rasim; Karpuz, M Hakan; Karadag, Bilgehan; Iktimur, Baris; Raimoglu, Utku; Soysal, Ali Ugur; Kargin, Osman Aykan; Güven, Mehmet; Malikova, Namina; Çitak, Elif; Yurtseven, Ece; Durmaz, Eser.
Afiliação
  • Raimoglou D; Department of Cardiology, Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Istanbul, Türkiye.
  • Izgi C; Department of Cardiology, Royal Brompton and Harefield Hospitals, London, United Kingdom.
  • Enar R; Department of Cardiology, Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Istanbul, Türkiye.
  • Karpuz MH; Department of Cardiology, Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Istanbul, Türkiye.
  • Karadag B; Department of Cardiology, Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Istanbul, Türkiye.
  • Iktimur B; Department of Cardiology, Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Istanbul, Türkiye.
  • Raimoglu U; Department of Cardiology, Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Istanbul, Türkiye.
  • Soysal AU; Department of Cardiology, Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Istanbul, Türkiye.
  • Kargin OA; Department of Radiology, Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Istanbul, Türkiye.
  • Güven M; Department of Medical Biology, Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Istanbul, Türkiye.
  • Malikova N; Department of Medical Biology, Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Istanbul, Türkiye.
  • Çitak E; Department of Medical Biology, Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Istanbul, Türkiye.
  • Yurtseven E; Department of Cardiology, Koç University Faculty of Medicine, Istanbul, Türkiye.
  • Durmaz E; Department of Cardiology, Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Istanbul, Türkiye.
Anatol J Cardiol ; 28(3): 150-157, 2024 Mar.
Article em En | MEDLINE | ID: mdl-38419512
ABSTRACT

BACKGROUND:

Hypertrophic cardiomyopathy (HCM) is a genetically inherited cardiac disorder with diverse clinical presentations. Adrenergic activity, primarily mediated through beta-adrenoceptors, plays a central role in the clinical course of HCM. Adrenergic stimulation increases cardiac contractility and heart rate through beta-1 adrenoceptor activation. Beta-blocker drugs are recommended as the primary treatment for symptomatic HCM patients to mitigate these effects.

METHODS:

This prospective study aimed to investigate the impact of common ADRB-1 gene polymorphisms, specifically serine-glycine at position 49 and arginine-glycine at position 389, on the clinical and structural aspects of HCM. Additionally, the study explored the association between these genetic variations and the response to beta-blocker therapy in HCM patients.

RESULTS:

A cohort of 147 HCM patients was enrolled, and comprehensive assessments were performed. The findings revealed that the Ser49Gly polymorphism significantly influenced ventricular ectopic beats, with beta-blocker therapy effectively reducing them in Ser49 homozygous patients. Moreover, natriuretic peptide levels decreased, particularly in Ser49 homozygotes, indicating improved cardiac function. Left ventricular outflow obstruction, a hallmark of HCM, was also reduced following beta-blocker treatment in all patient groups. In contrast, the Arg389Gly polymorphism did not significantly impact baseline parameters or beta-blocker response.

CONCLUSION:

These results emphasize the role of the Ser49Gly polymorphism in the ADRB-1 gene in shaping the clinical course and response to beta-blocker therapy in HCM patients. This insight may enable a more personalized approach to managing HCM by considering genetic factors in treatment decisions. Further research with larger populations and longer follow-up periods is needed to confirm and expand upon these findings.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Polimorfismo Genético / Cardiomiopatia Hipertrófica Limite: Humans Idioma: En Revista: Anatol J Cardiol Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Polimorfismo Genético / Cardiomiopatia Hipertrófica Limite: Humans Idioma: En Revista: Anatol J Cardiol Ano de publicação: 2024 Tipo de documento: Article